发明名称 |
Evaluation, assays and treatment of pKal-mediated disorders |
摘要 |
<p>The invention provides assay methods of detecting plasma protease CI inhibitor (Cl- INH) that binds plasma kallikrein, Factor XII, or both, and uses thereof for identifying subjects at risk for or suffering from a pKal-mediated or bradykinin-mediated disorder. Provided methods permit analysis of patients with plasma kallikrein-mediated angioedema (KMA), or other diseases mediated by pKal useful in the evaluation and treatment.</p> |
申请公布号 |
AU2014207409(A1) |
申请公布日期 |
2015.07.23 |
申请号 |
AU20140207409 |
申请日期 |
2014.01.17 |
申请人 |
DYAX CORP. |
发明人 |
JOSEPH, KUSUMAM;KAPLAN, ALLEN P. |
分类号 |
G01N33/48;C12Q1/56;G01N33/50 |
主分类号 |
G01N33/48 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|